Quantification of myocardial hypoperfusion with 99mTc-sestamibi in patients undergoing prolonged coronary artery balloon occlusion

Nuclear Medicine Communications

Volumn 23, Issue 3, 2002, Pages 219-228

  Persson, E ^a   Palmer, J ^b   Pettersson, J ^b   Warren, S G ^c   Borges Neto, S ^c   Wagner, G S ^c   Pahlm, O ^c  

^a CHARLESTON AREA MEDICAL CENTER   (United States)

^b LUND UNIVERSITY   (Sweden)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

99mTc sestamibi; Coronary artery disease; Myocardial SPECT; PTCA

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE PERFUSION; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MATHEMATICAL MODEL; QUANTITATIVE ANALYSIS; RIGHT CORONARY ARTERY; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMPUTER SIMULATION; CORONARY CIRCULATION; CORONARY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0036100445     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200203000-00004     Document Type: Article

References (22)

1. Gibbons RJ, Verani MS, Behrenbeck T, et al. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989; 80: 1277-1286.
2. Huber KC, Bresnahan JF, Bresnahan DR, Pellikka PA, Behrenbeck T, Gibbons RJ. Measurement of myocardium at risk by technetium-99m-sestamibi: correlation with coronary angiography. J Am Coll Cardiol 1992; 19: 67-73.
3. Haronian HL, Remetz MS, Sinusas AJ, et al. Myocardial risk area defined by Tc-99m-sestamibi imaging during percutaneous transluminal coronary angioplasty: comparison with coronary angiography. J Am Coll Cardiol 1993; 22: 1033-1043.
4. Steg PG, Faraggi M, Himbert D, et al. Comparison using dynamic vectorcardiography and MIBI SPECT of ST-segment changes and myocardial MIBI uptake during percutaneous transluminal coronary angioplasty of the left anterior descending coronary artery. Am J Cardiol 1995; 75: 998-1002.
5. Ceriani L, Verna E, Giovanella L, Bianchi L, Roncari G, Tarolo GL. Assessment of myocardial area at risk by technetium-99m sestamibi during coronary artery occlusion: comparison between three tomographic methods of quantification. Eur J Nucl Med 1996; 23: 31-39.
6. Sinusas AJ, Trautman KA, Bergin JD, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitril. Circulation 1990; 82: 1424-1437.
7. DeCoster PM, Wijns W, Cauwe F, Robert A, Beckers C, Melin JA. Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. Circulation 1990; 82: 2152-2162.
8. Verani MS, Jeroudi MO, Mahmarian JJ, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m-hexakis-2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988; 12: 1573-1581.
9. Pfisterer M, Müller-Brand J, Spring P, Bassignana V, Kiowski W. Assessment of the extent of jeopardized myocardium during acute coronary artery occlusion followed by reperfusion in man using technetium-99m isonitrile imaging. Am Heart J 1991; 122: 7-12.
10. Braat SH, DeSwart H, Rigo P, Koppejan L, Heidendal GAK, Wellens HJJ. Value of technetium MIBI to detect short lasting episodes of severe myocardial ischemia and to estimate the area at risk during coronary angioplasty. Eur Heart J 1991; 12: 30-33.
11. Gallik D, Obermuller S, Swarna U, Guidry G, Mahmarian J, Verani M. Simultaneous assessment of myocardial perfusion and left ventricular function during transient coronary occlusion. J Am Coll Cardiol 1995; 25: 1529-1538.
12. Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301-311.
13. Cardiolite product monography. Du Pont Nemours GmbH, Dreieich, Germany. p. 11.
14. Savi A, Gerundini P, Zoli P, et al. Biodistribution of Tc-99m methoxy-isobutyl isonitrile (MIBI) in humans. Eur J Nucl Med 1989; 15: 597-600.
15. Selvester R, Wagner G, Hindman N. The development and application of the Selvester QRS scoring system for estimating myocardial infarct size. Arch Intern Med 1985; 145: 1877-1881.
16. Anderson W, Wagner N, Lee K, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. VI: Identification of screening criteria for non-acute myocardial infarcts. Am J Cardiol 1988; 61: 729-733.
17. DePuey EG, Berman DS, Garcia EV. Cardiac SPECT imaging. New York: Raven Press, 1995: 63-74.
18. Garcia EV, Cooke CD, Van Train KF, et al. Technical aspects of myocardial SPECT imaging with technetium-99m sestamibi. Am J Cardiol 1990; 66: 23E-31E.
19. Pennell DJ, Prvulovich E. Diagnosis in coronary artery disease. In: Ell PJ, series editor. Nuclear cardiology. London: British Nuclear Medicine Society, 1995: 88.
20. Segall GM, Atwood JE, Botvinick EH, Dae MW, Lucas JR. Variability of normal coronary anatomy: implications for the interpretation of thallium-SPECT myocardial perfusion images in single-vessel disease. J Nucl Med 1995; 36: 944-951.
21. Klarich KW, Christian TF, Higano ST, Gibbons RJ. Variability of myocardium at risk for acute myocardial infarction. Am J Cardiol 1999; 83: 1191-1195.
22. Takeishi Y, Sukekawa H, Fujiwara S, Ikeno E, Sasaki Y, Tomoike H. Reverse redistribution of technetium-99m sestamibi following direct PTCA in acute myocardial infarction. J Nucl Med 1996; 37: 1289-1294.